BullFrog AI Holdings (BFRGW) Prepaid Assets (2022 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Prepaid Assets came in at $336994.0 in Q2 2026, up 47.26% on a YoY basis from $228837.0 in Q2 2025, and down 15.85% quarter-over-quarter from $400451.0 in Q4 2025.
Analysis
BullFrog AI Holdings (BFRGW) Prepaid Assets (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Prepaid Assets for 5 consecutive years, with $336994.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets rose 47.26% year-over-year to $336994.0; the trailing twelve-month figure through Jun 2026 stood at $336994.0 (up 47.26% YoY), and the FY2025 full-year result was $400451.0, up 258.84% from the prior year.
- Prepaid Assets slipped to $336994.0 in Q2 2026 per BFRGW's latest filing, from $400451.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $806298.0 in Q1 2023 and bottomed at $15000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $370623.6 across 5 years, with a median of $355485.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets surged 872.55% in 2023, then tumbled 55.72% in 2025.
- Over 5 years, Prepaid Assets stood at $15000.0 in 2022, then soared by 872.55% to $145882.0 in 2023, then dropped by 23.5% to $111597.0 in 2024, then surged by 258.84% to $400451.0 in 2025, then declined by 15.85% to $336994.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $336994.0, $400451.0, and $487018.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 336,994.00 |
| Dec 31, 2025 | 400,451.00 |
| Sep 30, 2025 | 487,018.00 |
| Jun 30, 2025 | 228,837.00 |
| Mar 31, 2025 | 280,126.00 |
| Dec 31, 2024 | 111,597.00 |
| Sep 30, 2024 | 358,537.00 |
| Jun 30, 2024 | 457,355.00 |
| Mar 31, 2024 | 632,596.00 |
| Dec 31, 2023 | 145,882.00 |
| Sep 30, 2023 | 352,433.00 |
| Jun 30, 2023 | 575,606.00 |
| Mar 31, 2023 | 806,298.00 |
| Dec 31, 2022 | 15,000.00 |